AstraZeneca shot’s benefits still outweigh its risks, European Medicines Agency says The European Union’s drugs regulator said a link between AstraZeneca Plc’s Covid-19 vaccine and a rare type of blood clot is possible, identifying at least 62 cases of the condition while insisting the shot’s benefits still outweigh its risks. The comments further cloud the picture around the vaccine after Germany restricted it to older people this week amid growing concerns about side effects. That could slow Europe’s already lagging immunization program as virus cases surge anew. The European Medicines Agency said…
Read MoreEU regulator Sees possible link between AstraZeneca shots, Blood Clots
